Logo Image
News|Slideshows|December 23, 2025

Top Five Prostate Cancer Imaging Content in 2025

Catch up on the most well-viewed prostate cancer imaging content from 2025.

We take a look back at the most well-viewed prostate cancer (PCa) imaging content from 2025 with topics ranging from the prognostic value of baseline PSMA PET/CT in patients with metastatic castration-resistant prostate cancer (mCRPC) and the potential of abbreviated MRI for imaging of clinically significant prostate cancer (csPCa) to a meta-analysis examining the use of PSMA PET for detecting PCa recurrence and metastasis. Review the slideshow below to see highlighted PCa imaging content from the past year.

Related Content

Latest CME

25th Annual International Congress on the Future of Breast Cancer® East
Video

25th Annual International Congress on the Future of Breast Cancer® East

Joyce O’Shaughnessy, MD

View more
25th Annual International Congress on the Future of Breast Cancer® West
Video

25th Annual International Congress on the Future of Breast Cancer® West

Sara A. Hurvitz, MD, FACP; Joyce O’Shaughnessy, MD

View more
Ready for Radioligand Therapy? Patient Selection and Sequencing Simplified
Multimedia

Ready for Radioligand Therapy? Patient Selection and Sequencing Simplified

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Scott T. Tagawa, MD, MS, FACP, FASCO

View more
Working Together: Overcoming Barriers to Optimize Outcomes in Patients Treated With Radioligand Therapy Through Multidisciplinary Care
Multimedia

Working Together: Overcoming Barriers to Optimize Outcomes in Patients Treated With Radioligand Therapy Through Multidisciplinary Care

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Nerina McDonald, MSPAS, PA-C; Scott T. Tagawa, MD, MS, FACP, FASCO

View more
Tennessee Oncology Practice Society
Virtual Event

Tennessee Oncology Practice Society

2 Sessions are Available!

View more